NCT07373054Completed
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia
Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia: A Prospective, Randomized, Controlled Clinical Trial
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Fujian Medical University Union Hospital
- Participants (registry)
- 18
- Start
- November 2025
- Primary completion
- July 2026
- Study completion
- August 2026
- Last registry update
- September 2026
- Countries
- China
Conditions studied: Androgenic Alopecia
Interventions: Topical Minoxidil, Electric Microneedling, Traditional Exosome Lyophilized Powder, Innovative Exosome Lyophilized Powder
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.